Atlas Trials

A Phase I/II Study of Sunitinib and Dacarbazine

Clinical trial NCT00496223 · TERMINATED

Trial details

NCT number
NCT00496223
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2006-09-01
Primary completion
2007-06-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.